Login / Signup

Tafenoquine for Relapsing Babesiosis: A Case Series.

Peter J KrauseRalph RogersMonika K ShahHeeEun KangJeffrey ParsonnetRich KodamaEdouard Vannier
Published in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America (2024)
Tafenoquine can be a useful adjunct for the treatment of highly immunocompromised patients experiencing relapsing babesiosis caused by B. microti.
Keyphrases
  • multiple sclerosis
  • end stage renal disease
  • ejection fraction
  • newly diagnosed
  • chronic kidney disease
  • peritoneal dialysis
  • disease activity
  • intensive care unit